Randomized, double-blind, placebo-controlled trial of autologous blood therapy for atopic dermatitis

• Published in: British journal of dermatology (1951) Vol. 148; no. 2; pp. 307 - 313
• Main Authors: Pittler, M.H., Armstrong, N.C., Cox, A., Collier, P.M., Hart, A., Ernst, E.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Science Ltd 01.02.2003; Blackwell; Oxford University Press
• Subjects: Adult; Allergic diseases; alternative medicine; atopic dermatitis; autologous blood therapy; Biological and medical sciences; Blood Transfusion, Autologous - methods; Dermatitis, Atopic - complications; Dermatitis, Atopic - therapy; dermatology; Double-Blind Method; eczema; Female; Humans; Immunopathology; Male; Medical sciences; Pruritus - complications; Quality of Life; randomized controlled trial; Severity of Illness Index; Skin allergic diseases. Stinging insect allergies; Sleep; Treatment Outcome; Human; Allergy; Immunopathology; Skin disease; Transfusion; Immunomodulation; Autologous system; Injection; Intramuscular administration; Blood; Atopy; randomized controlled trial; Treatment; dermatology; Atopic dermatitis; Alternative medicine; autologous blood therapy; Double blind study; eczema

Summary Background Autologous blood therapy (ABT) is used for treating atopic dermatitis (AD) in some European countries and is promoted on internet sites for this condition. However, there is little evidence from rigorous clinical trials to suggest that it is effective. Objectives To test the effec...